Education
About Us
Working with TipRanks
Follow Us
Misbah Tahir Insider Profile
11 Followers
Misbah Tahir, CFO at IGM Biosciences, holds 170.06K shares in IGM Biosciences (Ticker: IGMS), holds ― shares in Maze Therapeutics, Inc. (Ticker: MAZE). Most recently, Misbah Tahir Sold ― shares of IGM Biosciences on Jul 25, 2025 for an estimated value of $11.10K.
Profitable Transactions
9 out of 13 Profitable Transactions
Average Return
+38.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Misbah Tahir does not currently own shares as a corporate insider.
A breakdown of Misbah Tahir's holdings
Insider Roles
Chief Financial Officer
Roles that Misbah Tahir holds in companies
Most Profitable Insider Trade
Stock:
IGM Biosciences
(IGMS)
(IGMS)
Rating:Informative Sell
Date:Sep 17, 2024 - Today
Return:+92.80%
The most profitable trade made by Misbah Tahir
Misbah Tahir's Trading History
IGM Biosciences
Jul 25, 2025
―
Informative Sell
11.10K
$215.98K
Maze Therapeutics, Inc.
―
Chief Financial Officer
―
―
List of latest transactions for each holding click on a transaction to see Misbah Tahir's performance on stock
You May Also Like
Misbah Tahir insider profile FAQ
What is the percentage of profitable transactions made by Misbah Tahir?
The percentage of profitable transactions made by Misbah Tahir is 69%.
What is the average return per transaction made by Misbah Tahir?
The average return per transaction made by Misbah Tahir is 38.60%.
What stocks does Misbah Tahir hold?
Misbah Tahir holds: IGMS, MAZE stocks.
What was Misbah Tahir’s latest transaction?
Misbah Tahir latest transaction was an Informative Sell of $11.10K.
What was Misbah Tahir's most profitable transaction?
Misbah Tahir’s most profitable transaction was an Informative Sell of IGMS stock on September 17, 2024. The return on the trade was 92.80%.
What is Misbah Tahir's role in IGM Biosciences?
Misbah Tahir's role in IGM Biosciences is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.